Iron Metabolism and Inflammatory Mediators in Patients with Renal DysfunctionTomomi Matsuoka, Hiroki Kobayashi, Masanori Abe|International Journal of Molecular Sciences|2024Cited by 32
The prognostic value of serum hepcidin-25 in predicting cardiovascular events among maintenance hemodialysis patients: insights from the INFINITY cohortTomomi Matsuoka, Hiroki Kobayashi, Takashi Maruyama et al.|Clinical and Experimental Nephrology|2025Cited by 3
Limited Utility of Serum Hepcidin as a Marker for Erythropoiesis‐Stimulating Agent Hyporesponsiveness in Hemodialysis Patients: An Analysis From the <scp>INFINITY</scp> CohortTomomi Matsuoka, Hiroki Kobayashi, Chinami Nagura et al.|Therapeutic Apheresis and Dialysis|2025Cited by 1